Antifungal susceptibility testing of Candida albicans by flow cytometry
- PMID: 12950899
- DOI: 10.1046/j.1439-0507.2003.00903.x
Antifungal susceptibility testing of Candida albicans by flow cytometry
Abstract
Antifungal susceptibilities of 28 Candida albicans isolates and two quality control strains to amphotericin B and fluconazole were determined by flow cytometry and microdilution method. Minimum inhibitory concentrations (MICs) obtained by flow cytometry were compared with the results obtained by The National Committee for Clinical Laboratory Standards Subcommittee (NCCLS) broth microdilution method. The agreement of results (within two dilution) obtained was found as 96 and 93% for amphotericin B and fluconazole, respectively. At least 24 h incubation was required for reading the microdilution assays. Four hours of incubation was required for fluconazole, whereas 2-h incubation was sufficient for amphotericin B to provide MIC by flow cytometry. Results of this study show that flow cytometry provides a rapid and sensitive in vitro method for antifungal susceptibility testing of Candida albicans isolates.
Similar articles
-
Rapid flow cytometric susceptibility testing of Candida albicans.J Clin Microbiol. 1997 Sep;35(9):2320-4. doi: 10.1128/jcm.35.9.2320-2324.1997. J Clin Microbiol. 1997. PMID: 9276410 Free PMC article.
-
Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans.J Clin Microbiol. 2004 May;42(5):2249-51. doi: 10.1128/JCM.42.5.2249-2251.2004. J Clin Microbiol. 2004. PMID: 15131203 Free PMC article.
-
Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.Antimicrob Agents Chemother. 1996 Sep;40(9):1998-2003. doi: 10.1128/AAC.40.9.1998. Antimicrob Agents Chemother. 1996. PMID: 8878570 Free PMC article.
-
Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans.J Clin Microbiol. 1997 Jun;35(6):1473-6. doi: 10.1128/jcm.35.6.1473-1476.1997. J Clin Microbiol. 1997. PMID: 9163465 Free PMC article.
-
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.J Clin Microbiol. 1996 Mar;34(3):489-95. doi: 10.1128/jcm.34.3.489-495.1996. J Clin Microbiol. 1996. PMID: 8904400 Free PMC article. Review.
Cited by
-
Susceptibility tests of oropharyngeal Candida albicans from egyptian patients to fluconazole determined by three methods.Braz J Microbiol. 2012 Jan;43(1):266-73. doi: 10.1590/S1517-838220120001000031. Epub 2012 Jun 1. Braz J Microbiol. 2012. PMID: 24031828 Free PMC article.
-
Two promising natural lipopeptides from Bacillus subtilis effectively induced membrane permeabilization in Candida glabrata.Acta Biochim Pol. 2024 Jan 31;71:11999. doi: 10.3389/abp.2024.11999. eCollection 2024. Acta Biochim Pol. 2024. PMID: 38721306 Free PMC article.
-
An AIE-active probe acts as novel tool for rapid and accurate quantitative antifungal susceptibility assessment.Front Microbiol. 2025 Mar 27;16:1566846. doi: 10.3389/fmicb.2025.1566846. eCollection 2025. Front Microbiol. 2025. PMID: 40212389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources